Sarepta Therapeutics, Inc. (SRPT)
23.82
+0.68
(+2.92%)
USD |
NASDAQ |
Jan 09, 16:00
23.75
-0.08
(-0.31%)
After-Hours: 20:00
Sarepta Therapeutics Research and Development Expense (Annual): 778.47M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Arrowhead Pharmaceuticals, Inc. | 585.26M |
| Amgen, Inc. | 5.676B |
| Bristol Myers Squibb Co. | 9.782B |
| Alnylam Pharmaceuticals, Inc. | 1.126B |